Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 11 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (4)
P 2 (3)
P 3 (2)
P 4 (1)

Trial Status

Completed6
Not Yet Recruiting2
Recruiting1
Withdrawn1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06648850Phase 2Not Yet Recruiting

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

NCT07303322Phase 3Not Yet RecruitingPrimary

Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)

NCT07300813Not ApplicableActive Not Recruiting

Olistic_2025 for Hair Loss, Hair Growth, and Skin Improvement

NCT07096323Not ApplicableCompletedPrimary

Successful Treatment of Female Pattern Hair Loss With Injection of Nanofat With and Without Platelet-Rich Plasma

NCT06440655Not ApplicableRecruitingPrimary

The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients

NCT04090801Phase 4CompletedPrimary

Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss

NCT02206802Completed

Minoxidil Response Testing in Females With Female Pattern Hair Loss

NCT00175617Phase 2CompletedPrimary

Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss

NCT02486848Not ApplicableWithdrawnPrimary

Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil

NCT01900041Phase 2CompletedPrimary

A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss

NCT00958750Phase 3Completed

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

Showing all 11 trials

Research Network

Activity Timeline